AN UP-TO-DATE OPEN-ACCESS COURSE ON HPV-BASED CERVICAL CANCER SCREENING (ID 658)

Presenter
Authors

Previous ePoster
BARRIERS AND FACILITATORS TO CERVICAL CANCER SCREENING IN BOTSWANA (ID 643)

Next ePosters
MAXIMIZING THE IMPACT OF CERVICAL SCREENING IN THE PUBLIC SECTOR IN BRAZIL: DESCRIPTION OF A SELECTIVE RISK-BASED APPROACH (ID 661)
BARRIERS TO RECRUITMENT OF OLDER MSM INTO A CLINICAL RESEARCH STUDY ON ANAL HPV; A SUB-STUDY OF THE ANAL HPV, HIV, AND AGING (AHHA) STUDY (ID 670)
WOMEN’S PERCEPTIONS ABOUT SELF-COLLECTING SPECIMENS FOR HPV TESTING (ID 802)
HPV TESTING WAS AN EQUITABLE SOLUTION BY ACCELERATING ACCESS TO TREATMENT OF WOMEN WITH ≥ASC-US CYTOLOGY IN A PRAGMATIC RANDOMIZED TRIAL:AN ANALYSIS OF THE ASCUS-COL-TRIAL. (ID 869)
DIAGNOSTIC ACCURACY OF CONVENTIONAL PAPANICOLAU SMEAR, LIQUID BASED CYTOLOGY AND VIA IN DETECTING PREMALIGNANT AND MALIGNANT CERVICAL LESIONS AMONG FILIPINO WOMEN (ID 874)
BARRIERS AND FACILITATORS OF ANAL CANCER SCREENING IN PEOPLE LIVING WITH HIV IN PUERTO RICO (ID 943)
TEACHERS AND HEALTHCARE PROVIDERS PLAY A CRUCIAL ROLE IN SUSTAINING THE SUCCESS OF HPV VACCINATION PROGRAMMES – EVIDENCE FROM SEDIBENG DISTRICT. (ID 94)
EVALUATION OF VACCINE AND NON-VACCINE-TYPE HPV PREVALENCE AMONG HIV SERONEGATIVE YOUNG ADULTS FEMALES AND MALES IN BOTSWANA FOR FUTURE HPV VACCINE IMPACT MONITORING (ID 119)
SENSITIVITY OF SELF-REPORTED HUMAN PAPILLOMAVIRUS (HPV) VACCINATION HISTORY AMONG 18–26 YEAR-OLD MEN WHO HAVE SEX WITH MEN — SEATTLE, WASHINGTON, 2016–2018 (ID 126)
IMMUNIZATION CHALLENGES: VARIABILITY IN INPATIENT HOSPITAL FORMULARY INCLUSION OF ROUTINE ADULT VACCINES (ID 141)